What does Corbus Pharmaceuticals Holdings, Inc. do?
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a…
What is Corbus Pharmaceuticals Holdings, Inc.'s P/E and P/B ratio?
Corbus Pharmaceuticals Holdings, Inc. has a P/E ratio of -0.7 and a P/B ratio of 0.78.
What is Corbus Pharmaceuticals Holdings, Inc.'s debt-to-equity ratio?
Corbus Pharmaceuticals Holdings, Inc. has a debt-to-equity ratio of 0.04.
How much does Corbus Pharmaceuticals Holdings, Inc. owe compared with what it owns?
Corbus Pharmaceuticals Holdings, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Corbus Pharmaceuticals Holdings, Inc.'s Positivity rank?
Corbus Pharmaceuticals Holdings, Inc. is ranked #1,631 of 6,774 companies globally and #389 of 4,000 in United States on PositoAI, with a Positivity Score of 22,476.
Does Corbus Pharmaceuticals Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Corbus Pharmaceuticals Holdings, Inc..
Where can I read the latest news about Corbus Pharmaceuticals Holdings, Inc.?
Recent headlines about Corbus Pharmaceuticals Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Corbus Pharmaceuticals Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Corbus Pharmaceuticals Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.